Cryptocurrency
Oobit expands crypto payments service to Colombia
Oobit officially launched its crypto payments platform in Colombia, marking the company’s ninth active market as it expands further across Latin America.
Mahathir Bayena
Crypto JournalistCrypto journalist for Grafa, with nearly 10 years of experience covering blockchain, Web3, and NFT gaming trends. MBA & Economics grad.
Contact
Contact editorial teamArticles by Mahathir Bayena
Oil and Gas
Condor Energy formalises South American exploration strategy
Australian oil and gas explorer Condor Energy (ASX:CND) has formalised its ongoing exploration and corporate strategy.
Cryptocurrency
Intesa Sanpaolo doubles crypto holdings to $235M
Intesa Sanpaolo more than doubled its cryptocurrency exposure during the first quarter of 2026, increasing holdings from around $100 million at the end of 2025 to approximately $235 million by March 31, according to a report from Criptovaluta.it.
CervoMed reports progress on Phase 3 dementia trial infrastructure alongside Q1 results
CervoMed (NASDAQ:CRVO) reported its financial results for the first quarter of 2026, alongside corporate and clinical milestones for its lead oral small-molecule drug candidate, neflamapimod.
-4-640x360.webp&w=3840&q=75)
AFT Pharmaceuticals names Stuart Houliston as CFO
AFT Pharmaceuticals (ASX:AFP) announced the appointment of Stuart Houliston as its new CFO, effective June 15.
Philips Group secures major Stockholm contract for hospital-at-home care
Philips (NYSE:PHG), in partnership with healthcare technology firms Cuviva and Vingmed, has been selected by Region Stockholm to implement a large-scale hospital-at-home program.
Technology
RenX Enterprises revenue rises 20% on biomass and logistics demand
RenX Enterprises (NASDAQ:RENX) reported strong sequential revenue expansion for the first quarter of 2026, driven by higher utilization across its contracted hauling agreements and accelerating bulk material sales, even as advanced technology integration costs left consolidated bottom-line metrics in a deficit.
FDA accepts BioXcel’s at-home agitation drug application for review
BioXcel Therapeutics (NASDAQ:BTAI) announced that the U.S. Food and Drug Administration has formally accepted a supplemental New Drug Application for its lead neuropsychiatric drug, providing a clear regulatory catalyst as the company manages tightening capital constraints.
Purple Biotech narrows Q1 net loss as cancer pipeline progresses
Purple Biotech (NASDAQ:PPBT) reported its financial and operational results for the first quarter of 2026, highlighting clinical milestones within its immunotherapy pipeline and a stabilized bottom line supported by non-operating income.
American Strategic Investment revenue slides on Manhattan property sale
American Strategic Investment (NYSE:NYC) reported a decline in first-quarter 2026 revenue, reflecting the structural contraction of its New York City commercial real estate portfolio following a major property exit.